Big Pharma's Favorite: A Rare Disease Biotech Nearing Major Milestone

Biotech firms with rare disease treatments are top takeover targets and this company is nearing Phase 2. The drug is aimed at high-need pediatric brain disorders and holds both U.S. and EU orphan drug status.

Below is an important message from one of our valued partners along with today's top headlines.

Big Pharma's Favorite: A Rare Disease Biotech Nearing Major Milestone - Ad Biotech firms with rare disease treatments are top takeover targets and this company is nearing Phase 2. The drug is aimed at high-need pediatric brain disorders and holds both U.S. and EU orphan drug status. Explore the science and investment potential. This message is sent on behalf of Polaryx Therapeutics. Musth Corp receives a fixed fee for each subscriber that clicks on a link in this email. See our disclaimer for further details. Alibaba And SMIC Power Beijing's Bid To End Reliance On Nvidia And ASML Alibaba secures China Unicom as major client for AI chips amid Beijing's push for domestic alternatives. SMIC begins trial runs of advanced lithography machine. Continue reading ➔ The Fed Just Got Kneecapped - Here's What Happens Next - Ad A new law, S.1582, has just kneecapped the Federal Reserve - handing select companies the legal authority to mint a new form of American money. Investors who move now could see 40X gains by 2032... while the rest are left scrambling, wondering how they missed it. Go here now for details before October 16. Bitcoin, Dogecoin, XRP Gain; Ethereum Trades Flat: Analyst Predicts ETH Reversal Before Q4 Parabolic Rally Leading cryptocurrencies rose in tandem with stocks on Monday, as investors increased their risk appetite ahead of key inflation data reports. Continue reading ➔ Von der Leyen proposes bolder EU sanctions against Israel over the war in Gaza ANTWERP, Belgium (AP) — European Commission President Ursula von der Leyen broke Wednesday with her pro-Israel stance and announced plans to seek sanctions and a partial trade suspension against Israel over . Continue reading ➔ Elon's $25 Trillion Confession - Ad Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world. See Tesla's REAL master plan here Cathie Wood, Dan Ives Align On These 11 AI Stock Picks — Some Might Surprise You Cathie Wood and Dan Ives have 11 stocks in common across ETFs. A look at the AI stocks the two key figures are betting on. Continue reading ➔ Detailed findings from AP investigation into how US tech firms enabled China's digital police state BEIJING (AP) — American tech companies to a large degree designed and built China’s surveillance state, playing a far greater role in enabling human rights abuses than previously known, . They sold billions of dollars of technology to the Chinese police, government and surveillance companies, despite and that such tools were being used to , and . Continue reading ➔ What's inside Elon's building in Memphis will shock you - Ad Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the October 1st funding window closes. Continue reading ➔ Trump Ally Charlie Kirk Assassinated At Utah Event, FBI Releases Initial Suspect As Kash Patel Vows 'Transparency' Conservative political activist Charlie Kirk was shot and killed on Wednesday while speaking at Utah Valley University in Orem, sparking a federal investigation that has taken an unusual turn with the FBI's public handling of suspect information on social media. Continue reading ➔ Amazon spends $1 billion to increase pay and lower health care costs for US workers NEW YORK (AP) — Amazon says it's making a $1 billion investment to raise wages and lower the cost of health care plans for its U.S. fulfillment and transportation workers. Continue reading ➔ October 16 Changes the Microchip Game - and Investing - Ad George Gilder-dubbed "America's #1 Futurist"-says while everyone's chasing AI, the real opportunity is in a 4-nanometer tech millions of times more complex. It's not another chip - it replaces them. Now built in Arizona, Gilder says 3 companies tied to this "super-convergence" could soar. Get his complete research here. Trump Makes Chinese Stocks Great Again — Until Someone Mentions Tariffs President Donald Trump's recent optimistic remarks on negotiations with China have given a boost to U.S.-listed Chinese stocks.  Continue reading ➔ Jim Cramer: This Is The Right Time To Buy This Energy Stock Mad Money's Jim Cramer looks at Phillips 66 and Intuitive Surgical, as well as Tandem Diabetes Care and Cintas. Continue reading ➔ Bitcoin Gets The Jitters Around $115,000: Up Or Down Ahead Of FOMC Day? Bitcoin's (CRYPTO: BTC) tapped $116,000 before retracing below $115,000 on Monday, signaling that fresh catalysts may be needed to lift sentiment as weakening metrics signal a potential pullback. Continue reading ➔ Donald Trump Declares Harsh Media Coverage of Him 'No Longer Free Speech' But 'Illegal' President Donald Trump has labeled negative media coverage of him as "illegal." Continue reading ➔ Donald Trump Calls For Soros To Be Imprisoned: 'He's A Bad Guy' President Trump has advocated for the imprisonment of billionaire Democratic donor George Soros. Continue reading ➔ FBI Finds John Bolton's Personal Email Was Breached By Foreign Entity The personal email account of former National Security Adviser John Bolton was reportedly compromised by a foreign entity. Continue reading ➔

Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault. 2967 Dundas St. W. #990, Toronto, ON M6P 1Z2, 917.672.7040 © 2025 Musth | PriceActionEA | All rights reserved. Unsubscribe

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: